1Jia WP, Xiang KS, Chen L, et al.Epidemiological study on obesity and its comorbiditied in urban Chinese older than 20 yesrs of age in Shanghai,China.Obesity Reviews, 2003,3:157-165.
2.
3Caglayan E, Blaschke F, Takata Y, et al.Metabolic syndrome-interdependence of the cardiovascular and metabolic pathways.Curr Opin Pharmacol, 2005,5:135-142.
4Turner RC, Millns H, Neil HA, et al.Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus:United Kingdom Prospective Diabetes Study (UKPDS) 23.BMJ,1998,316:823-828.
5Laakso M:Hyperglycaemia and cardiovascular disease in patients with type 2 diabetes.Curr Opin Endocrinol Diabetes,2000,7:197-202.
6DECODE Study Group.Glucose tolerance and mortality:comparison of WHO and merican Diabetes Association diagnostic criteria.The DECODE study group.European Diabetes Epidemiology Group.Diabetes Epidemiology:Collaborative analysis of diagnostic criteria in Europe.Lancet,1999,354:617-621.
7Brownlee M.The pathobiology of diabetic complications:a unifying mechanism.Diabetes, 2005,54:1615-1625.
8Schachinger V, Britten MB, Zeiher AM.Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.Circulation, 2000,101:1899-1906.
9Suwaidi JA, Hamasaki S, Higano ST, et al.Longterm follow-up of patients with mild coronary artery disease and endothelial dysfunction.Circulation, 2000,101:948-954.
